1. Home
  2. XWIN vs AVIR Comparison

XWIN vs AVIR Comparison

Compare XWIN & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XWIN

XMAX Inc.

N/A

Current Price

$6.03

Market Cap

249.2M

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.57

Market Cap

236.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XWIN
AVIR
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.2M
236.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
XWIN
AVIR
Price
$6.03
$3.57
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
902.6K
375.3K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,959,274.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
70.36
N/A
52 Week Low
$0.41
$2.46
52 Week High
$6.23
$4.02

Technical Indicators

Market Signals
Indicator
XWIN
AVIR
Relative Strength Index (RSI) N/A 64.57
Support Level N/A $3.11
Resistance Level N/A $3.72
Average True Range (ATR) 0.00 0.12
MACD 0.00 0.04
Stochastic Oscillator 0.00 74.80

Price Performance

Historical Comparison
XWIN
AVIR

About XWIN XMAX Inc.

XMax Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: